Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

NACDS hire will aid Capitol Hill efforts: The National Association of Chain Drugs Stores brings aboard J. Anne Foley as director of political affairs to help engage members in greater political involvement. The Alexandria, Va.-based trade group said Aug. 23 Foley will enhance the organization's fundraising capabilities and improve collaboration between NACDS' political action committee and its state-level efforts. Foley reports to VP of Federal Affairs Paul Kelly. She comes to NACDS from a political program management function at the Credit Union National Association and also worked at the National Mining Association

You may also be interested in...



New Products In Brief

Stridex Naturally Clear adds botanicals: Blistex Inc. extends its alcohol-free acne pad line with the antioxidant benefits of white tea, pomegranate and soy to promote stronger, healthier skin, according to the company. Stridex Naturally Clear pads contain the acne-fighting ingredient salicylic acid and are designed to maximize cleaning coverage, the Oak Brook, Ill.-based firm says May 12. Blistex offers Stridex Naturally Clear in 55-, 70- and 90-count stock-keeping units, at suggested prices ranging from $3.49 to $6.49

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS104453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel